加入收藏
Industry Information
3D printing will continue to focus on the domestic pharmaceutical manufacturers
administrators 2016-11-10 17:12:14

"The biggest challenge for clinical application of 3D printing stage or in the process of charging, as medical 3D printing fee has not been approved, there is more research funding in the clinical, but this is not a long-term solution." The day before, Shanghai on children with congenital heart disease institute professor Liu Jinfen said in the "First Financial Daily" interview with reporters, the clinical application of 3D printing stage has been in CFDA (State Food and Drug Administration) of the application process, is expected to be granted or two.

Computer modeling is more important than print

"For the treatment of complex congenital heart disease, it often takes more than 5 to 8 hours. And if we can print before the surgery, simulation, you can make a better understanding of the operation of the doctor is expected to increase the success rate of surgery." Liu Jinfen said.

According to him, after ten years of development, the application of 3D printing in the field of cardiac surgery has long gone out of the heart of the initial stage of model printing, computer simulation + printing can provide a better solution for doctors.

To belong to the Shanghai Children's Medical Center under the "pediatric 3D digital medical research center had successfully completed a hemodynamic simulation research as an example, through the design and Simulation of hemodynamics in virtual surgery, vividly demonstrates the prediction procedure of hemodynamic parameter and quantitative change and flow trajectory, so as to provide reliable information in order to reduce the risk of surgery.

As everyone knows, the heart is the development of a human embryo is the earliest organ to form and function, is closely related to influence the growth process and hemodynamics, in the treatment, the use of computer simulation and analysis of dynamic characteristics of blood flow, clinicians can carry out the design of a body of medical image three dimensional reconstruction of computer aided 3D based on virtual surgery, in order to find the operation scheme of patients with individualized hemodynamics.

At present, this technology has such as extracardiac conduit FONTAN surgery, pulmonary artery banding, improved pulmonary shunt, and airway malformation, sternal deformity patients to provide a more accurate treatment plan.

In addition, the research center of the 3D staff can also print individual anatomical models using computer reconstruction technique, to help doctors more intuitive understanding of the anatomical structure of individual patients in the preoperative cardiovascular heart defects, such as shape, size, location, extent, and the surrounding tissue structure.

"For difficult, complex rare patients, we recommend the use of such a 3D solution, if it can be extended to the clinic, the future of 3%~5% patients can benefit from the heart." Liu Jinfen said.

3D printing industry is still far away

3D printing from the dream into reality, still have to cross the two important threshold, one is the upstream of the software design, the other is the service charge.

3D printing software and service providers (Materialise) general manager Marius China Kim Francois on the "First Financial Daily reporters, at present, Japan has some of the costs of producing 3D printing technology is included in the insurance clauses, such as: according to the three-dimensional reconstruction of the lesions of patients with CT data, surgery planning and rehearsal for such a set of service and handling, insurance can be reimbursed about 1800 yuan. However, in the country, 3D printing is still not part of the compliance of clinical charges of medical services, there is no insurance company can provide the appropriate reimbursement services.

"The future trend of this industry is the industry, but now everyone is on research funding in the exploration of 3D printing operation application, this is not a permanent solution." Liu Jinfen said, but according to him, the current 3D printing service has been declared in the process of CFDA, and is expected to be approved within one or two years.

Another difficulty of industrialization lies in the breakthrough of software technology.

"These years we have seen a lot of domestic 3D printing service providers, they can say is not inferior to imported manufacturers in the print service, even more cost-effective, but in the design of the 3D model, that is to say in the strength of the software and the import manufacturers still have a gap." Liu Jinfen revealed.

He said that the domestic 3D printing suppliers mainly the current competition is still the focus of manufacturing sectors in the downstream of the print, but this part of the actual profit space is limited, but there is still much room for development in the simulation of operation design, 3D medical service on the computer, the current domestic manufacturers did not receive wide attention, including the Materialise import swept the domestic manufacturers early 3D printing computer design services, according to the first financial reporter, these import suppliers occupy more than 90% market share.

In fact, sometimes we will feel a headache, because many hospitals will use some software piracy, so in clinical use will encounter various problems, but in other countries less likely to encounter this kind of situation." Kim Francois said.

 

下一页:3D pen into the student art class

沪ICP备13025774号-4
Copyright © cocolove All Rights
技术支持:锐虎网络

Shanghai Xunzhan Convention & Exhibition Co. Ltd (Chifu exhibition company wholly-owned Affiliated Companies)

address:Rm 803, Jinyu Lan Square, No.1 Dapu Road, Shanghai Zip code:200023
Switchboard:021-63045419 mailbox:dmefair@xt-sh.com
Fax:021-64181136 Website:http://www.dmefair.com